Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Tofacitinib significantly improved skin and hair conditions without side effects.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Topical cyclosporin-A is recommended for severe alopecia areata.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

Tofacitinib taken by mouth helps treat hair loss in children.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.